July 15, 2020
100 outbreaks tackled a week
Mr Hancock said increased testing meant officials could now be “targeted” in their response. This is at a time when … Read More “100 outbreaks tackled a week”
July 14, 2020
GP Patient Survey 2020
Around one in five patients (21.7%) say they tried to contact an NHS service in the past 12 months when … Read More “GP Patient Survey 2020”
July 13, 2020
Restart of medical tests and fitness to practise work
The GMC has set out its plans for resuming Professional and Linguistic Assessment Board 2 (PLAB 2) tests for overseas … Read More “Restart of medical tests and fitness to practise work”
July 10, 2020
35,000 extra UK cancer deaths
There are concerns routine screenings, urgent referrals and treatments have been delayed or cancelled. Scientists suggest there could be at … Read More “35,000 extra UK cancer deaths”
July 9, 2020
Online COVID-19 rehab service
People who are suffering long-term effects of coronavirus will benefit from a revolutionary on-demand recovery service. It follows the building … Read More “Online COVID-19 rehab service”
July 8, 2020
PM’s as partners
After initially announcing that PM’s would be excluded from the new Partnership scheme launched on 1st July, it appears NHS … Read More “PM’s as partners”
July 7, 2020
Health and social care key issues
This briefing brings together and summarises some of the key issues that Members have raised on behalf of their constituents … Read More “Health and social care key issues”
July 6, 2020
HEE launches new resource pack
New resources are aimed at easing student doctors into Foundation training and supporting them during the programme. The resources will … Read More “HEE launches new resource pack”
July 3, 2020
Outstanding BAME risk assessments
NHS England has written to GP practices asking them to complete risk assessments for at-risk staff within four weeks. It … Read More “Outstanding BAME risk assessments”
July 2, 2020
NICE guidance does not recommend siponimod
NICE has issued draft guidance for public consultation which does not recommend siponimod for treating secondary progressive multiple sclerosis (MS). … Read More “NICE guidance does not recommend siponimod”